CompletedNot Applicable

Nutritional Status in Neuroblastoma in Sao Paolo, Brazil

Brazil17 participantsStarted 2018-07-15

Plain-language summary

This study proposes to investigate the effect of treatment of neuroblastoma on nutritional status, assessed by body mass index (BMI) z score, and body composition evaluated by mid-upper arm circumference (MUAC), from diagnosis through 1-year post end of treatment. The study also aims to investigate the nutritional status and its role in toxicities, infection, survival rates, disease relapse, cost of care and readmission rates, as well as health-related quality of life. The study will take place in Sao Paolo in Brazil, where an estimated sample of 50 children with neuroblastoma will be recruited for the period of 2 years.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of high-risk neuroblastoma at ITACI, according to the Pediatric Oncology Group (POG)/Children's Cancer Study Group (CCG) classification (International Neuroblastoma Staging System (INSS) stage) * Age under 18 years * Informed consent from a legal guardian to participate in the study Exclusion Criteria: * Patients who have received previous chemotherapy * First assessment performed more than 48 hours after the beginning of treatment

What they're measuring

Body Mass Index Z Score

Timeframe: Up to 1 year post treatment

Mid-upper arm circumference (MUAC)

Timeframe: Up to 1 year post treatment

Measurement from Bioelectrical Impedance Analysis (BIA)

Timeframe: Up to 1 year post treatment

Trial details

NCT IDNCT03517280

SponsorColumbia University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-05-10

View on ClinicalTrials.gov More Neuroblastoma trials